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African Americans have a lower colorectal cancer 
screening rate than whites and higher disease incidence 
and mortality. Despite wide acceptance of colonoscopy for 
accurate screening, increasing promotion of high-sensitivity 
stool test screening, such as the fecal immunochemical 
test (FIT), may narrow racial, ethnic, and socioeconomic 
disparities in screening. This study provides formative 
research data to develop an intervention to increase 
colorectal cancer screening among underinsured and 
uninsured African Americans in central North Carolina.
Methods
We held 4 focus groups to explore knowledge, beliefs, and 
attitudes about colorectal cancer screening, particularly 
FIT. Participants (n = 28) were African American adults 
recruited from neighborhoods with high levels of poverty 
and unemployment. Constructs from the diffusion of inno-
vation theory were used to develop the discussion guide.
Results
In all groups, participants noted that lack of knowledge 
about colorectal cancer contributes to low screening use. 
Attitudes about FIT sorted into 4 categories of “innovation 
characteristics”: relative advantage of FIT compared with 
no screening and with other screening tests; compatibility 
with personal beliefs and values; test complexity; and test 
trialability. A perceived barrier to FIT and other stool tests 
was risk of incurring costs for diagnostic follow-up.
Conclusion
Community-based FIT screening interventions should 
include provider recommendation, patient education to 
correctly perform FIT, modified FIT design to address 
negative attitudes about stool tests, and assurance of 
affordable follow-up for positive FIT results.
Introduction
Screening for colorectal cancer (CRC), the second lead-
ing cause of cancer death in the United States, leads to 
increased early detection and treatment of this disease 
(1). Although 62% of the US population reports following 
recommended CRC screening guidelines, screening rates 
are lower for those with lower incomes and those without 
health insurance (2). Rates are also thought to be lower 
among African Americans, who are more likely than 
other ethnic groups to be diagnosed with late-stage CRC 
(2) and 40% more likely than whites to die of CRC (3).
Adults at average risk for CRC may choose from sev-
eral screening options. Until recently, organizations that 
develop and issue guidelines were generally in consensus 
about which tests to endorse. The US Preventive Services 
Task Force (USPSTF) recommends that patients choose 
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from among yearly high-sensitivity fecal occult blood test 
(FOBT) or high-sensitivity fecal immunochemical test 
(FIT), flexible sigmoidoscopy every 5 years, or colonoscopy 
every 10 years. Each screening regimen is clinically effec-
tive for reducing mortality (4,5).
In 2008, the American Cancer Society (ACS), in collabora-
tion with the US Multi-Society Task Force on Colorectal 
Cancer and the American College of Radiology, issued a 
slightly diverging set of recommendations, adding stool 
DNA and computed tomographic colonoscopy tests. The 
ACS guidelines also categorize tests according to their 
potential to detect versus prevent CRC. The first category 
includes FOBT and FIT. The second category includes 
screening tests that produce visual images of the colon 
and, therefore, can detect and guide removal of adeno-
matous polyps, a benign precursor of most colorectal 
cancers, thereby preventing them from developing into 
cancer (6).
With either set of guidelines, patients must choose a test 
that most closely aligns with their needs and values. Each 
test conveys distinct benefits and limitations related to 
test frequency, cost, invasiveness, sensitivity, specificity, 
convenience, and regional availability. For lay and profes-
sional audiences alike, determining the relative advantage 
of the various screening tests is a complex issue.
FOBT and FIT are the least expensive options and do not 
require access to endoscopy facilities. Some types of FIT 
are increasingly preferred over FOBT because the tests 
are specific to human hemoglobin and have a similarly 
high or higher sensitivity (7). Vitamins, foods, and drugs 
do not alter FIT accuracy, and patients may find it easier 
to use. Improving access to FIT has potential to increase 
screening by reducing costs and removing some structural 
barriers, such as geographically distant endoscopy facili-
ties (8-12).
The objective of this study was to provide formative 
research data for an intervention to increase CRC screen-
ing in a target population of underinsured and uninsured 
African Americans living in a metropolitan area in central 
North Carolina. We conducted focus groups with members 
of the target population to explore knowledge, beliefs, and 
attitudes about CRC screening, particularly FIT. Focus 
group data are being used to inform the design of a FIT 
screening intervention.
Methods
Theoretical framework: diffusion of innovations
The diffusion of innovations theory describes the adoption 
of new practices or products (innovations) and the factors 
that accelerate or impede their spread throughout a com-
munity. Application of this theory during intervention 
planning can help cancer prevention and control practitio-
ners develop dissemination strategies specific to different 
CRC screening tests and populations.
The theory posits that perceptions of an innovation’s char-
acteristics affect how quickly and widely the innovation 
is adopted. Five attributes that explain 49% to 87% of 
variance in adoption rates are relative advantage, com-
patibility, complexity, trialability, and observability (13). 
Relative advantage is the degree to which a potential user 
perceives the innovation as superior to the practice that 
it supersedes. Compatibility refers to the beliefs about 
whether the innovation is consistent with personal values. 
Complexity is the extent to which the user perceives the 
innovation as difficult to use. Trialability is the degree 
to which someone can experiment with the innovation 
before adopting it. Potential users can also conduct a 
vicarious trial by observing and learning from someone 
else’s experimentation (13). Observability is the extent 
to which results of adopting an innovation are visible to 
others. Modifying FIT in ways that affect perceptions of 
these 5 attributes in the target population can enhance or 
diminish its diffusion potential. Intervention planning also 
requires audience and community assessment research to 
understand how an innovation is likely to interact with 
individual and environmental characteristics. Elements in 
the diffusion of innovation theory guided the organization 
and presentation of the focus group results.
Procedures
Starting in January 2007, a local community research advi-
sory board, a standing group that advises about research 
projects in several North Carolina counties, reviewed the 
research protocol, recommended appropriate honoraria 
for participants, and guided the research team in dissemi-
nating results locally. The institutional review board 
of the University of North Carolina at Chapel Hill also 
approved this study. Community organizations assisted 
in early spring 2007 by posting flyers and allowing study 
staff to attend their outreach events to recruit and enroll 
participants. Potential participants contacted research 
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staff in person at these events or by telephone after seeing 
recruitment materials. Two study staff administered brief 
eligibility surveys and enrolled participants.
Eligible participants were African Americans aged 50 years 
or older who were not at elevated risk for CRC because of 
a family history of CRC in a first-degree relative or a 
personal history of the disease. Those screened by FOBT 
or FIT within the past year or by any endoscopy method 
or contrast barium enema within the past 5 years were 
excluded. Of 51 people who completed eligibility screen-
ing, 16 were ineligible because of age or recent screening. 
Thirty-five eligible people received assignment to a male 
or female focus group session (there were 2 of each), a 
confirmation letter, and a reminder letter and telephone 
call. Of those, 28 attended 1 of 4 two-hour focus groups and 
completed a brief demographic questionnaire in March 
2007. Focus groups of 5 to 9 people were conducted at 2 
African American churches of different denominations 
and at a community resource center. The churches and the 
resource center were recommended as neutral sites that 
were likely to be familiar and geographically accessible to 
participants. Eligible participants chose to attend either 
a weekend morning or weekday evening focus group. The 
study covered taxi costs for participants without transpor-
tation. All participants received a $30 gift certificate.
Focus group members gave written consent for their 
participation. A trained African American facilitator of 
the same sex as participants moderated the focus groups. 
All groups were tape recorded. Facilitators followed a 
semistructured guide with preset probes (Appendix) to 
ensure conversation depth. The moderator began with 
questions about participants’ knowledge and attitudes 
about CRC and screening. After distributing a 3-sample 
Hemoccult ICT packet, an FIT manufactured and donated 
by Beckman Coulter, Inc (Brea, CA), the moderator asked 
participants to examine the packet and share opinions 
about its design, packaging, instructions, and usability. 
The moderator also asked participants questions about 
community characteristics and local health services, and 
participants were able to ask questions or raise topics that 
they thought were important but had not been addressed.
Analysis
Verbatim transcription of audio recordings produced 191 
pages of text. The first author used Atlas.ti software 
(Atlas.ti Scientific Software Development GmbH, Berlin, 
Germany) to conduct a content analysis followed by 
thematic analysis. Content analysis examined the degree of 
consensus in responses to questions and generated a list of 
codes that defined overarching themes. The analyst coded 
and ranked each comment from most to least frequently 
mentioned. A second analyst also reviewed transcripts, 
and differences in the analyses were resolved.
Thematic analysis entailed grouping codes by themes, 
which were defined by elements of diffusion of innovation 
theory. Qualifying findings had to emerge in at least 2 
groups. A finding’s strength increased if it occurred in 3 or 
all 4 groups. To count as a finding for women, a code had 
to occur in both women’s groups, and likewise for the men. 
During thematic analysis, the analyst abstracted quotes 
that illustrated findings.
Results
Half of study participants reported an annual income of 
less than $10,000 (Table). Twenty participants reported 
having a regular health care provider, yet only 13 had ever 
spoken with a provider about CRC. More women than men 
reported talking with a health care provider about CRC.
Themes are presented in terms of individual, innovation, 
and environmental characteristics that, following diffu-
sion of innovation theory, are likely to influence FIT adop-
tion. Comments about FIT aligned with 4 of the 5 innova-
tion characteristics believed to predict adoption: relative 
advantage of FIT compared to no screening or other CRC 
screening, compatibility of FIT with personal beliefs and 
preferences, complexity of the FIT procedures, and strate-
gies to enhance FIT’s trialability. Participant comments 
did not directly address the innovation’s observability; 
however, the low profile of CRC screening emerged as a 
related theme.
Individual characteristics: awareness and knowledge of 
CRC and CRC screening
Across all groups, awareness and knowledge of CRC and 
screening were low. Female participants said that CRC 
screening is discussed less frequently than breast or cervi-
cal cancer screening.
You know, you do tell people “I went for a mammo-
gram” because one of the things that women do dis-
cuss when they go for a mammogram is . . . how the 
test felt, you know, what was done. We talk about 
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Pap[anicolaou] smears. But I just never, ever heard 
anybody say anything when they go for their physi-
cal about [CRC screening]. (Woman, group C)
Innovation characteristics: perceptions about FIT screening
Relative advantage
Most participants noted that finding cancer early is benefi-
cial relative to late diagnoses, and most indicated that FIT 
screening was preferable to other CRC screening tests. 
Several men said that they liked the idea of a home test 
for CRC.
There was a time I was, uh, the doctors wanted to 
take that [colonoscopy] for me and I wouldn’t allow 
them because that’s a part of my body. I just, just 
can’t see nobody doing what they do. So, I told them 
“Ain’t there no other way you can test it?” (Man, 
group A)
When differences between FOBT and FIT were discussed, 
FIT was preferred because it requires no food restric-
tions.
Compatibility
Negative attitudes about FIT were due mostly to percep-
tions of the test as “gross.” Women expressed more reluc-
tance about collecting and storing stool samples than men 
and noted that people may be deterred by smelly odors or 
embarrassment when returning the samples. All groups 
discussed problems associated with storing stool samples. 
Some recommended adding a device to hold used sample 
cards until they go to the lab.
No one thinks to let it dry completely overnight. So, 
I guess you have to put this someplace where — I 
don’t know — You know, because you got to let it 
dry completely, and you don’t want to just leave it 
on the sink. (Man, group D)
Participants also said stool tests are a good screening 
option for those preferring home remedies to medical ser-
vices.
Participants generally approved of the appearance of FIT 
packaging; however, they thought that the thin, light-
weight materials could easily be overlooked or discarded.
If I don’t really have an understanding of how 
important it is, I’ll just discard it, you know, 
because it looks like another piece of mail. So, it 
just goes in the garbage can with all my other mail. 
(Man, group D)
Complexity
Although most said FIT is a simple procedure, in every 
group participants said FIT’s multistep instructions 
would challenge some people. Instructions in small type 
were acknowledged as a potential problem for low literacy 
patients. Not understanding the rationale for each step 
of the FIT procedure, which is performed over several 
days, bothered some participants: “Okay, you’re gonna 
put 2 [pieces of stool] on it, 1 for the bottom, 1 for the 
top. Then you’re going to smear [them] together. For 
what?” (woman, group B). Another participant said, “All 
the processes . . . Lift the toilet seat. Attach it to fit you. 
Measuring tissue. . . . You know, it’s a lot to do. A lot to do 
for me” (man, group A). 
Others shared similar concerns.
I think before they give a person a kit like that, 
they just educate them on why they’re doing it 
and what they should do, what they’re going to be 
looking for. ’Cause if they just give it and tell them 
to take it home, bring their stool sample back, I 
mean they haven’t told them nothing. (Woman, 
group B)
Trialability
A few had previously tried and completed a 3-sample 
FOBT. One man explained that “there’s nothing to it” 
(group D). Another participant described how a female 
health care provider helped him practice a test procedure 
before he attempted it independently.
They went through the whole thing with me. Cause 
I didn’t know exactly how to do it. Cause I can read 
and I can guess. . . . She said, “I’m gonna sit here 
and we’ll go through the whole process.” Then you 
know exactly what to do. (Man, group D)
In addition to hands-on instruction, video or illustrations 
were suggested by the participants to improve adherence 
to test procedures.
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Observability
The silence surrounding CRC was discussed in all groups. 
One woman (group C) compared the invisibility of CRC 
screening with other screenings: “We hear a lot about 
mammograms . . . we hear a lot about cervical cancer . 
. . and the importance of Pap[anicolaou] smears. But we 
don’t really hear a lot about colon cancer.” Although ben-
efits of early detection or prevention of cancer are not eas-
ily observed, negative consequences of late-stage cancer 
diagnosis are, prompting such remarks as “a lot of people 
[are] afraid of taking the necessary steps as far as being 
examined. I guess they’re scared of what they will find out” 
(woman, group C).
Environmental characteristics with potential to affect FIT 
screening
Provider recommendation
Lack of provider recommendation appeared as a screening 
impediment: “If the doctor tells me this [FIT] is something I 
must do, or I have to do it, I just have to humble myself and 
get it done. But until that time, man, I’ll just take my per-
sonal beliefs and use them” (man, group A). Participants 
described physicians as important health information 
sources, yet rarely discussed CRC with a doctor.
Health care cost and access
Even if free CRC screening were available, participants 
said they might opt out unless affordable follow-up is 
assured. In the absence of diagnostic care and treatment, 
screening may be pointless: “The cost factor. If I do [have 
cancer], I can’t afford to continue with the treatment or 
whatever is needed to be done. Therefore, if I don’t start 
and I don’t know, I won’t have to follow through” (man, 
group A).
Discussion
The National Commission on Prevention Priorities 
ranked CRC screening as the fourth most valuable clinical 
preventive service that medical practices can offer (14). 
Although some tests, particularly colonoscopy, have 
ardent supporters, most people agree that USPSTF- or 
ACS-recommended tests increase early detection of CRC 
(1,15) and that patients should be able to choose a test 
they prefer. Results from published studies indicate that 
patients do not unanimously favor one test over another; 
some studies indicate FOBT and FIT are least preferred 
(16,17). Others show some patients preferring stool tests 
over colonoscopy (9,18). Findings from our study suggest 
that FIT is perceived as an acceptable or preferred CRC 
screening test relative to other screening tests, including 
colonoscopy. Fisher et al (12) report that using annual 
stool tests for primary screening would allow 100% of 
the age-appropriate US population to be screened at a 
savings of nearly $10 billion per decade from what is 
currently spent to screen only half the targeted population. 
For cancer prevention and control planners working to 
extend CRC screening to underinsured and uninsured 
patients, our findings suggest FIT is viable for community 
screening. Participant comments exposed factors that 
could impede widespread adoption and should be taken 
into consideration when planning screening programs that 
include FIT.
Complexity of test procedures emerged as a concern. For 
innovations requiring acquisition of new skills, diffusion 
tends to be slow (13). FIT screening entails following multi-
step instructions over a span of several days. Other studies 
have found that people often lack skills and confidence to 
successfully complete stool tests (11,19,20). Another focus 
group study reported that clearer instructions about test 
procedures would improve participation rates (11). Similarly, 
participants in our study recommended adding instructions 
in large type and illustrations of test procedures.
Participants also recommended hands-on practice ses-
sions using sample materials or video demonstrations. In 
addition to reducing complexity, these activities address 
the concept of trialability by allowing patients to try FIT 
before committing to using it at home. Three-sample FIT 
and FOBT are already designed with a certain degree of 
trialability: patients can gain confidence in doing the test 
as they attempt to collect a sample each day. Although 
test accuracy decreases with an incomplete sampling, 1 or 
2 samples can still be analyzed. The next year, the patient 
will have another opportunity to perform the test.
Our focus group participants indicated that handling or 
mailing stool samples is embarrassing and mildly offen-
sive, hence incompatible activities. Similar attitudes have 
been reported about FOBT (20-22). In an Australian study 
of FOBT use, the 2 main reasons, together accounting for 
almost 50% of reasons for nonadherence, were perceived 
unpleasantness and inconvenience (22). Participants in 
our study noted that merely adding a storage device to 
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securely contain fecal samples until they are returned to 
the doctor may make FIT more acceptable.
In addition to the innovation characteristics of FIT screen-
ing, the public’s low awareness of stool testing may impede 
adoption (11,19,20,23,24). The effectiveness of mass media 
interventions for increasing CRC screening deserves fur-
ther research (25); however, the most important source 
of information about CRC screening is health care pro-
fessionals (23,26). Although physician recommendation 
for screening is a leading predictor of screening adher-
ence (23,26), only 13 of 28 participants in this study had 
talked with a health care provider about CRC. Physicians 
have reported not recommending CRC screening to unin-
sured patients if access to diagnostic care is lacking (11). 
Participants noted that FIT screening has little value 
unless diagnostic follow-up services are available and 
affordable. In regions where CRC screening programs 
do not fund screening and diagnostic colonoscopy for the 
underinsured and uninsured, adhering to CRC screening 
guidelines is a challenge.
Focus group data, while offering great depth and detail 
in response to research questions, cannot be generalized 
beyond the sample. In our study, convenience sampling and 
the small sample size further decreased generalizability of 
the results. Also, only 1 researcher coded the content analy-
sis, potentially decreasing the validity of our findings.
CRC disproportionately affects the lives of African 
Americans, and screening rates must be increased to 
reduce the number of African American lives lost to the 
disease. Findings from our study and others indicate that 
FIT is a viable option for more widespread population-
based CRC screening.
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Table
Table. Characteristics of Participants in a 2007 Focus Group Study Conducted With African Americans (n = 28) in Central North 
Carolina
Characteristic Women Men Women and Men Combined
No. of participants 14 14 28
Average age, y 6  61
Annual income, <$10,000a   14
Annual income  $10,000-$19,000a 3 4 
Has a regular health provider 12 8 20
Has talked to provider about colorectal cancer 9 4 13
 
a Data on income were missing for 1 woman and 2 men.
Appendix
Please visit the online version of this article to view the Focus Group Moderator’s Guide (DOC 1k). This file is available for download as a Microsoft Word 
document.
